Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship
JR Molina, P Yang, SD Cassivi, SE Schild… - Mayo clinic …, 2008 - Elsevier
Lung cancer is the leading cause of cancer-related mortality not only in the United States but
also around the world. In North America, lung cancer has become more predominant among …
also around the world. In North America, lung cancer has become more predominant among …
Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis
SN Markovic, LA Erickson, RD Rao… - Mayo Clinic …, 2007 - Elsevier
Malignant melanoma is an aggressive, therapy-resistant malignancy of melanocytes. The
incidence of melanoma has been steadily increasing worldwide, resulting in an increasing …
incidence of melanoma has been steadily increasing worldwide, resulting in an increasing …
Pineal parenchymal tumors: clinical, pathologic, and therapeutic aspects
SE Schild, BW Scheithauer, PJ Schomberg, CC Hook… - Cancer, 1993 - Wiley Online Library
Background. Pineal parenchymal tumors are rare; therefore, only limited clinical data
regarding their behavior is available. This study was performed to provide further information …
regarding their behavior is available. This study was performed to provide further information …
Non–small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell
Lung Cancer (NSCLC) provide recommended management for patients with NSCLC …
Lung Cancer (NSCLC) provide recommended management for patients with NSCLC …
Non–small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology
This selection from the NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC)
focuses on targeted therapies and immunotherapies for metastatic NSCLC, because …
focuses on targeted therapies and immunotherapies for metastatic NSCLC, because …
NCCN guidelines insights: non–small cell lung cancer, version 2.2021: featured updates to the NCCN guidelines
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021 in: Journal of the
National Comprehensive Cancer Network Volume 19 Issue 3 (2021) Jump to Content User …
National Comprehensive Cancer Network Volume 19 Issue 3 (2021) Jump to Content User …
[HTML][HTML] Impact of intensity-modulated radiation therapy technique for locally advanced non–small-cell lung cancer: a secondary analysis of the NRG oncology RTOG …
SG Chun, C Hu, H Choy, RU Komaki… - Journal of Clinical …, 2017 - ncbi.nlm.nih.gov
Purpose Although intensity-modulated radiation therapy (IMRT) is increasingly used to treat
locally advanced non–small-cell lung cancer (NSCLC), IMRT and three-dimensional …
locally advanced non–small-cell lung cancer (NSCLC), IMRT and three-dimensional …
NCCN guidelines insights: non–small cell lung cancer, version 1.2020: featured updates to the NCCN guidelines
DS Ettinger, DE Wood, C Aggarwal, DL Aisner… - Journal of the National …, 2019 - jnccn.org
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of
management for NSCLC. These NCCN Guidelines Insights focus on recent updates in …
management for NSCLC. These NCCN Guidelines Insights focus on recent updates in …
NCCN guidelines® insights: non–small cell lung cancer, version 2.2023: featured updates to the NCCN guidelines
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) provide recommendations
for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus …
for management of disease in patients with NSCLC. These NCCN Guidelines Insights focus …
NCCN guidelines insights: non–small cell lung cancer, version 5.2018
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of
management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the …
management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the …